
Attending Urologic Surgeon, MAIN LINE HOSPITALS, INC.
Member of the Healthcare Council
Guy Bernstein, MD, is President and Practicing Urologist at the Center for Urologic Care in Bryn Mawr, Pennsylvania. In addition, Dr. Bernstein has served as Attending Urologic Surgeon at Bryn Mawr Hospital since 1988. He is experienced in all aspects of urology with special interest in erectile dysfunction, male infertility, incontinence, benign prostatic hypertrophy, prostatitis and prostate cancer. He is certified in laparoscopic and laser surgery, cryosurgery and brachytherapy for prostate cancer, minimal invasive heat treatments for BPH and sling procedures for male and female incontinence. Dr. Bernstein is Vice-Chairman of the Main Line Hospitals Institutional Review Board, and has participated in clinical trials for GlaxoSmithKline, Ortho-McNeil, Novartis, Genomics, Sanofi-Synthelabo, Solvay, Myriad, Dendreon and Pfizer. He is a member of the speaker's bureau for Ortho-McNeil, GlaxoSmithKline, Sanofi-Synthelabo, Lilly Icos and Auxilium. Dr. Bernstein has investigator experience with Provenge. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
ED and cardiovascular disease are linked
August 11, 2006
Impotence could be sign of heart disease, study says | www.cnn.com
Erectile dysfunction may be the first indicator of serious cardiovasulcar disease which warrants evaluation and treatment.
Crowded Field of OAB Medications
August 11, 2006
Trospium Chloride Meets Primary and Secondary Endpoints in Phase 3 Trial | www.ptcommunity.com
Phase III trial of Sanctura XR shows efficacy in treatment of OAB with reduced side effect of dry mouth.